Cancer-fighting T cells that appear to be exhausted may retain a surprising ability to leave tumors and establish long-lasting immune...

Drug resistance is one of the most persistent obstacles in modern cancer care, allowing malignant cells to survive treatments that...

Osteosarcoma, a rare but aggressive bone cancer that most often strikes children and adolescents, is at the center of a...

Charles W.M. Roberts Named Next President and CEO of St. Jude Children’s Research Hospital The Board of Governors of St....

CAR T-cell therapy has changed the outlook for people with some of the most aggressive blood cancers, turning a patient’s...

Cancer treatment is rarely limited to the cancer itself. Patients with advanced disease may also develop bacterial or fungal infections,...

Researchers at the Yong Loo Lin School of Medicine at the National University of Singapore have identified a molecular “master...

Rectal cancer is often described as a disease of malignant cells, but the biology surrounding those cells can be just...

A retraction notice in Experimental & Molecular Medicine has withdrawn a high-profile claim about how the cancer-linked NOTCH signaling pathway...

Metabolic and alcohol-associated liver disease, or MetALD, is emerging as one of the most consequential—and least recognized—forms of chronic liver...